TGAFF yields 86.38% · JNJ yields 2.14%● Live data
📍 TGAFF pulled ahead of the other in Year 1
Combined, TGAFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TGAFF + JNJ for your $10,000?
Taiga Building Products Ltd. operates as a wholesale distributor of building products in Canada and the United States. It offers composite decking products, railings, and accessories; engineered wood products; laminate and vinyl floorings; insulation products; dimension lumber products; moldings; panels, such as plywood, oriented strand boards, and particleboards; polyethylene sheeting products; and preserved wood products, including fencing, landscape timbers, plywoods, preserved wood foundation, and pre-stained products. The company also provides roofing materials; batt and foam insulation products; siding and trim products; and wall coverings and accessories. In addition, it produces pressure-treated wood products. The company distributes its building products through 15 distribution centers in Canada, 2 distribution centers in the United States to building products retailers, building supply yards, and industrial manufacturers. It also exports its products to Asia, Central America, South America, and the Middle East. The company was founded in 1973 and is headquartered in Burnaby, Canada. Taiga Building Products Ltd. operates as a subsidiary of Avarga Limited.
Full TGAFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.